Cirugia y cirujanos · 2026
Liver transplant program outcomes at a Colombian center: 14 years of experience.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Licht-Ardila Maricel, Mosquera-Velasquez Giseth A, Abril-Lopera Angie V, Hurtado-Ortiz Alexandra, Olarte-Licht Luis A, Flórez-Suárez Santiago, Padilla-Padilla Lizeth C, David-Gonzalez Elizabeth C, Duarte-Yepes Joel, Mendoza-Monsalve Alejandra, Vásquez Skarlet M, Arenas-Peña Gabriel J, Vanegas-Ballesteros Mauricio, Tarazona-Leon Cristian E
Аннотация
OBJECTIVES: The objective of the study was to analyze outcomes of a liver transplant program over 14 years and evaluate associations between patient characteristics, surgical factors, complications, and mortality.
METHODS: A retrospective cohort study was conducted at a transplant center, including patients from 2011 to 2025. Descriptive statistics, X2, Mann-Whitney U tests, and multivariate logistic regression were used to identify mortality predictors. Kaplan-Meier survival analysis was also performed.
RESULTS: The study included 109 liver transplant recipients. Rejection rates were higher among deceased patients (30.3% vs. 13.2%, p = 0.034). One-year survival improved from 63.3% (2011-2014) to 89.1% (2023-2025), with 100% rejection-free survival in the most recent cohort. Complications like multi-organ failure, bronchopneumonia, acute renal failure, ventilatory failure with coma, and leukoencephalopathy significantly increased mortality risk (odds ratio 4.27, p = 0.002).
CONCLUSIONS: One-year survival has improved, with reduced rejection rates reflecting better post-transplant care. However, complications remain a major mortality risk. Shorter ischemia times indicate optimized surgical and logistical procedures.
METHODS: A retrospective cohort study was conducted at a transplant center, including patients from 2011 to 2025. Descriptive statistics, X2, Mann-Whitney U tests, and multivariate logistic regression were used to identify mortality predictors. Kaplan-Meier survival analysis was also performed.
RESULTS: The study included 109 liver transplant recipients. Rejection rates were higher among deceased patients (30.3% vs. 13.2%, p = 0.034). One-year survival improved from 63.3% (2011-2014) to 89.1% (2023-2025), with 100% rejection-free survival in the most recent cohort. Complications like multi-organ failure, bronchopneumonia, acute renal failure, ventilatory failure with coma, and leukoencephalopathy significantly increased mortality risk (odds ratio 4.27, p = 0.002).
CONCLUSIONS: One-year survival has improved, with reduced rejection rates reflecting better post-transplant care. However, complications remain a major mortality risk. Shorter ischemia times indicate optimized surgical and logistical procedures.